February 2017

This Continuing Education activity is supported by an educational grant from Nature Made Nutritional Products.

Although the neuropain inhibitor pregabalin (Lyrica) is frequently used to treat conditions such as epilepsy, neuropathic pain, and bromyalgia, the results of a recent pilot study suggest that the drug could also be used to ease pain related to irritable bowel syndrome (IBS).

Migraine and tension headaches could share some genetic links with irritable bowel syndrome (IBS), according to recent study results presented at the annual meeting of the American Academy of Neurology in Vancouver, Canada.

Psychological therapies are known to provide short-term symptom relief to patients with irritable bowel syndrome (IBS), but the results of a recent study indicate that these benefits may extend even longer than previously thought.

The World Gastroenterology Organization describes the prevalence of celiac disease as a “statistical iceberg” in today’s health climate.

Convenient care clinics (CCCs) provide a cost-effective alternative when primary care providers are unable to accommodate a patient with a last-minute appointment or provide treatment for an acute illness.

Approximately 60 million Americans experience heartburn once a month, and 15 million Americans suffer from it daily.

Prescription opioids are potent pain-relieving medications that, when used correctly, can effectively control pain and increase the quality of life for patients with acute or chronic pain.

The most common form of peptic ulcer is the duodenal ulcer, which typically occurs in the proximal segment.

Inflammatory bowel disease involves chronic inflammation of the inner tract of the intestine.

Clostridium difficile is a spore-forming, gram-positive bacteria spread by the fecaloral route.

The frequency and scale of global travel has led to unprecedented opportunity for rapid spread of emerging and reemerging diseases.

Read about the new Rx products featured in February 2017.

Read about the new OTC products featured in February 2017.

It’s hard to believe, but 2017 is well upon us, bringing with it a whole host of changes and new opportunities, which is how our industry thrives.

Strength and persistence are key American attributes, but collaborative effort is critical to success.